Frequently Asked Questions
How does the HiQCell procedure work?
The HiQCell procedure involves injecting a mixture of regenerative cells taken from a person's own adipose (fat) tissue into an affected joint or tendon. A large body of scientific evidence suggests that the regenerative cells may act by replacing lost or damaged cells, reducing inflammation, improving the function of cells at the site and recruiting cells from other parts of the body to assist in these processes. This is the focus of ongoing research for Regeneus.
How much does it cost?
Costs will vary depending upon the scope of the treatment; this is something that should be discussed with the treating medical specialist at the time of consultation. We are currently working with the relevant authorities to achieve a Medicare benefit, however at present no benefit is payable, either by Medicare or by a health fund. You may be able to claim a tax refund of 20% of the cost, if your total health costs are above $2,000 in a year. We recommend seeking independent advice in this area.
What is a Clinical Trial?
Clinical trials investigate medical interventions or medical therapies for human use. Participants in clinical trials are usually assigned to different groups to assess the effect of an intervention or therapy on a person's health.
There are often set criteria (called "eligibility criteria") to participate in a clinical trial and only people who meet all of the eligibility criteria for the trial can be enrolled.
In conducting clinical research, Regeneus is committed to following the Gold Standard of Clinical Research: Good Clinical Practice (GCP).
Is HiQCell a form of natural therapy or alternative medicine?
This treatment is, in every respect, conventional, science-based medicine. It has been developed by scientists for use by qualified and registered medical specialists.
Should I talk to my local GP about getting access to the HiQCell procedure?
It is always advisable to discuss health-related questions with your GP or other trusted medical doctor. Your doctor might not yet be aware of the HiQCell procedure. We are currently working hard to increase doctor awareness and knowledge about the HiQCell procedure and we are hopeful that the HiQCell procedure will be much more widely available within the next 12-18 months. Please see details of our current HiQCell Licensed Medical Specialists.
How is the HiQCell procedure different from other stem cell treatments?
The HiQCell procedure is a unique regenerative cell procedure for people with joint and tendon disease such as osteoarthritis and tendinopathy that involves injecting a mixture of regenerative cells taken from a person's own adipose (fat) tissue into an affected joint or tendon.
Adipose tissue is one of the richest sources of one particular type of regenerative cell called Mesenchymal Stem Cells (MSC). Mesenchymal Stem Cells are found in large numbers in adipose tissue and because of this there is no need to grow or manipulate the cells before using them.
The entire procedure takes no more than 3-4 hours and is performed by a trained specialist (a surgeon or physician) in a medical facility (typically a day hospital). In most cases, the procedure is performed under light sedation as an outpatient, with no need to stay overnight.
How safe is the HiQCell procedure?
The HiQCell procedure involves removal of tissue to collect regenerative cells and injection of the regenerative cells back into the body. There are some side effects and potential complications that should be considered before receiving treatment. These side effects are consistent with minor liposuction, and joint injection procedures. This should be discussed in more detail with the specialist who is performing the procedure, as they will be most familiar with their individual patients.
Side effects that have been reported are mainly related to the first stage of the HiQCell procedure. Most people experience some discomfort in the area where the regenerative cells are harvested from under the skin of the abdomen. This discomfort subsides over the first week following the procedure.